Bastian Beitzinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bastian Beitzinger has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Mika Lindén
Institute of Inorganic Chemistry II, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany
3 shared publications - Armando Rodriguez
ULMTeC Core Facility for Functional Peptidomics, Ulm University Medical Center, 89081 Ulm, Germany
1 shared publication - Christine Kranz
Institute of Analytical and Bioanalytical Chemistry Ulm University Ulm Germany
1 shared publication Fabian Gerbl
Institute of Medical Microbiology and Hygiene Ulm University Hospital Albert‐Einstein‐Allee 11 Ulm 89081 Germany
1 shared publicationGilbert Weidinger
Institute of Biochemistry and Molecular Biology Ulm University Albert‐Einstein‐Allee 11 Ulm 89081 Germany
1 shared publication- Gregor Neusser
Ulm University
1 shared publication
Latest Publications
- Open Access
- 27 July 2025
- Published by Wiley in Advanced Science
- Vol. 12 (36) , e08174
Precursor Inhomogeneities Influence the Properties of Multimetal Oxides as Shown for LiNi 0.5 Mn 1.5 O 4 Derived from Hydrothermally Synthesized Precursors
Co‐precipitation is an attractive means for synthesizing mixed metal oxides, a material class with a wide range of application prospects. Often soluble metal salts are precipitated as metal hydroxides or ‐carbonates, which subsequently are converted to the corresponding oxide(s) upon thermal treatment. The thermal treatment step is used to induce compositional homogeneity on the atomic level. In order to shed some more light on this effect, detailed analyses of a mixed Li‐Ni‐Mn‐oxide with the target composition LiNi 0.5 Mn 1.5 O 4 (LNMO), which is a promising cathode material for rechargeable Li‐ion batteries are performed. The first synthesis step is the precipitation of a Ni‐Mn‐carbonate, which is subsequently thermally lithiated and transformed into an oxide. A combination of X‐Ray diffraction (XRD), Raman microscopy, scanning electron microscopy coupled with energy dispersive X‐Ray spectroscopy (EDX) in combination with elemental analysis, as well as electrochemical characterization, revealed that chemical inhomogeneities present already in the precursor particles have a direct influence on the electrochemical performance of the final product. The broader implications of these results in relation to co‐precipitation‐based syntheses of functional materials are discussed, with special focus on the importance of the particle size distribution of the secondary particles.
- 27 July 2025
- Published by Wiley in Advanced Science
- Vol. 12 (36) , e08174
Open AccessPrecursor Inhomogeneities Influence the Properties of Multimetal Oxides as Shown for LiNi 0.5 Mn 1.5 O 4 Derived from Hydrothermally Synthesized Precursors
Co‐precipitation is an attractive means for synthesizing mixed metal oxides, a material class with a wide range of application prospects. Often soluble metal salts are precipitated as metal hydroxides or ‐carbonates, which subsequently are converted to the corresponding oxide(s) upon thermal treatment. The thermal treatment step is used to induce compositional homogeneity on the atomic level. In order to shed some more light on this effect, detailed analyses of a mixed Li‐Ni‐Mn‐oxide with the target composition LiNi 0.5 Mn 1.5 O 4 (LNMO), which is a promising cathode material for rechargeable Li‐ion batteries are performed. The first synthesis step is the precipitation of a Ni‐Mn‐carbonate, which is subsequently thermally lithiated and transformed into an oxide. A combination of X‐Ray diffraction (XRD), Raman microscopy, scanning electron microscopy coupled with energy dispersive X‐Ray spectroscopy (EDX) in combination with elemental analysis, as well as electrochemical characterization, revealed that chemical inhomogeneities present already in the precursor particles have a direct influence on the electrochemical performance of the final product. The broader implications of these results in relation to co‐precipitation‐based syntheses of functional materials are discussed, with special focus on the importance of the particle size distribution of the secondary particles.
- Open Access
- 17 June 2021
- Published by Wiley in Advanced Healthcare Materials
- Vol. 10 (14) , 2100453
Delivery by Dendritic Mesoporous Silica Nanoparticles Enhances the Antimicrobial Activity of a Napsin‐Derived Peptide Against Intracellular Mycobacterium tuberculosis
Tuberculosis remains a serious global health problem causing 1.3 million deaths annually. The causative pathogen Mycobacterium tuberculosis (Mtb) has developed several mechanisms to evade the immune system and resistances to many conventional antibiotics, so that alternative treatment strategies are urgently needed. By isolation from bronchoalveolar lavage and peptide optimization, a new antimicrobial peptide named NapFab is discovered. While showing robust activity against extracellular Mtb, the activity of NapFab against intracellular bacteria is limited due to low intracellular availability. By loading NapFab onto dendritic mesoporous silica nanoparticles (DMSN) as a carrier system, cellular uptake, and consequently antimycobacterial activity against intracellular Mtb is significantly enhanced. Furthermore, using lattice light‐sheet fluorescence microscopy, it can be shown that the peptide is gradually released from the DMSN inside living macrophages over time. By electron microscopy and tomography, it is demonstrated that peptide loaded DMSN are stored in vesicular structures in proximity to mycobacterial phagosomes inside the cells, but the nanoparticles are typically not in direct contact with the bacteria. Based on the combination of functional and live‐cell imaging analyses, it is hypothesized that after being released from the DMSN NapFab is able to enter the bacterial phagosome and gain access to the bacilli.
- 17 June 2021
- Published by Wiley in Advanced Healthcare Materials
- Vol. 10 (14) , 2100453
Open AccessDelivery by Dendritic Mesoporous Silica Nanoparticles Enhances the Antimicrobial Activity of a Napsin‐Derived Peptide Against Intracellular Mycobacterium tuberculosis
Tuberculosis remains a serious global health problem causing 1.3 million deaths annually. The causative pathogen Mycobacterium tuberculosis (Mtb) has developed several mechanisms to evade the immune system and resistances to many conventional antibiotics, so that alternative treatment strategies are urgently needed. By isolation from bronchoalveolar lavage and peptide optimization, a new antimicrobial peptide named NapFab is discovered. While showing robust activity against extracellular Mtb, the activity of NapFab against intracellular bacteria is limited due to low intracellular availability. By loading NapFab onto dendritic mesoporous silica nanoparticles (DMSN) as a carrier system, cellular uptake, and consequently antimycobacterial activity against intracellular Mtb is significantly enhanced. Furthermore, using lattice light‐sheet fluorescence microscopy, it can be shown that the peptide is gradually released from the DMSN inside living macrophages over time. By electron microscopy and tomography, it is demonstrated that peptide loaded DMSN are stored in vesicular structures in proximity to mycobacterial phagosomes inside the cells, but the nanoparticles are typically not in direct contact with the bacteria. Based on the combination of functional and live‐cell imaging analyses, it is hypothesized that after being released from the DMSN NapFab is able to enter the bacterial phagosome and gain access to the bacilli.